抗感染性眼科の世界市場2020-2026:抗菌剤、抗ウイルス剤、抗真菌剤、抗寄生虫剤、その他

QYResearchが発行した調査報告書(QYR20AP00112)
◆英語タイトル:Global Anti-infective Ophthalmic Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP00112
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥563,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥845,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,127,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、抗感染性眼科の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、抗感染性眼科のグローバル市場動向、メーカー別競争状況、種類別市場規模(抗菌剤、抗ウイルス剤、抗真菌剤、抗寄生虫剤、その他)、用途別市場規模(病院用、診療所用、家庭用、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・抗感染性眼科の種類別市場2015-2026:抗菌剤、抗ウイルス剤、抗真菌剤、抗寄生虫剤、その他
・抗感染性眼科の用途別市場2015-2026:病院用、診療所用、家庭用、その他
・抗感染性眼科の北米市場分析
・抗感染性眼科のアジア市場分析
・抗感染性眼科の中南米市場分析
・抗感染性眼科の中東・アフリカ市場分析
・関連企業情報:Novartis、Allergan、Bausch Health、Santen Pharmaceutical、Lupin Pharmaceuticals、Apotex、Akorn
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.In terms of region, the global ophthalmic anti-infective market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global ophthalmic anti-infective market due to availability of advanced drug formulations in the region. Awareness among people about diseases is also a major factor boosting the market in the region. The ophthalmic anti-infective market in Asia Pacific is anticipated to expand at a rapid pace due to increase in incidence of eye infection in the region. Lack of awareness about diseases and unavailability of advanced medication and formulations in underdeveloped countries, such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to restrain the growth of the ophthalmic anti-infective market in Middle East & Africa.
In 2019, the global Anti-infective Ophthalmic market size was US$ 1438.1 million and is forecast to US$ 1543 million in 2026, growing at a CAGR of 1.0% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Anti-infective Ophthalmic.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Anti-infective Ophthalmic market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Anti-infective Ophthalmic market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Anti-infective Ophthalmic market. Readers of the report can become informed about current and future trends of the global Anti-infective Ophthalmic market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Anti-infective Ophthalmic markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Anti-infective Ophthalmic market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Anti-infective Ophthalmic market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Anti-infective Ophthalmic market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Anti-infective Ophthalmic market is segmented into
Antibacterial
Antiviral
Antifungal
Anti-parasitic
Others

Market Segment by Application, the Anti-infective Ophthalmic market is segmented into
Hospital Use
Clinic Use
Household
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Novartis
Allergan
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn

The study objectives are:
To analyze and research the global Anti-infective Ophthalmic status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Anti-infective Ophthalmic manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anti-infective Ophthalmic are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Anti-infective Ophthalmic Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Anti-infective Ophthalmic Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Antibacterial
1.3.3 Antiviral
1.3.4 Antifungal
1.3.5 Anti-parasitic
1.3.6 Others
1.4 Market Segment by Application
1.4.1 Global Anti-infective Ophthalmic Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital Use
1.4.3 Clinic Use
1.4.4 Household
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Anti-infective Ophthalmic Revenue (2015-2026)
2.1.1 Global Anti-infective Ophthalmic Revenue (2015-2026)
2.1.2 Global Anti-infective Ophthalmic Sales (2015-2026)
2.2 Anti-infective Ophthalmic Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Anti-infective Ophthalmic Sales by Regions (2015-2020)
2.2.2 Global Anti-infective Ophthalmic Revenue by Regions (2015-2020)
2.3 Global Top Anti-infective Ophthalmic Regions (Countries) Ranking by Market Size
2.4 Anti-infective Ophthalmic Industry Trends
2.4.1 Anti-infective Ophthalmic Market Top Trends
2.4.2 Market Drivers
2.4.3 Anti-infective Ophthalmic Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Anti-infective Ophthalmic Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Anti-infective Ophthalmic Manufacturers by Sales (2015-2020)
3.1.1 Global Anti-infective Ophthalmic Sales by Manufacturers (2015-2020)
3.1.2 Global Anti-infective Ophthalmic Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Anti-infective Ophthalmic Sales in 2019
3.2 Global Top Manufacturers Anti-infective Ophthalmic by Revenue
3.2.1 Global Anti-infective Ophthalmic Revenue by Manufacturers (2015-2020)
3.2.2 Global Anti-infective Ophthalmic Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-infective Ophthalmic Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-infective Ophthalmic as of 2019)
3.4 Global Anti-infective Ophthalmic Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anti-infective Ophthalmic Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anti-infective Ophthalmic Market
3.7 Key Manufacturers Anti-infective Ophthalmic Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Anti-infective Ophthalmic Historic Market Review by Type (2015-2020)
4.1.2 Global Anti-infective Ophthalmic Sales Market Share by Type (2015-2020)
4.1.3 Global Anti-infective Ophthalmic Revenue Market Share by Type (2015-2020)
4.1.4 Anti-infective Ophthalmic Price by Type (2015-2020)
4.1 Global Anti-infective Ophthalmic Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Anti-infective Ophthalmic Sales Forecast by Type (2021-2026)
4.2.3 Global Anti-infective Ophthalmic Revenue Forecast by Type (2021-2026)
4.2.4 Anti-infective Ophthalmic Price Forecast by Type (2021-2026)

5 Global Anti-infective Ophthalmic Market Size by Application
5.1 Global Anti-infective Ophthalmic Historic Market Review by Application (2015-2020)
5.1.2 Global Anti-infective Ophthalmic Sales Market Share by Application (2015-2020)
5.1.3 Global Anti-infective Ophthalmic Revenue Market Share by Application (2015-2020)
5.1.4 Anti-infective Ophthalmic Price by Application (2015-2020)
5.2 Global Anti-infective Ophthalmic Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Anti-infective Ophthalmic Sales Forecast by Application (2021-2026)
5.2.3 Global Anti-infective Ophthalmic Revenue Forecast by Application (2021-2026)
5.2.4 Anti-infective Ophthalmic Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anti-infective Ophthalmic Breakdown Data by Company
6.2 North America Anti-infective Ophthalmic Breakdown Data by Type
6.3 North America Anti-infective Ophthalmic Breakdown Data by Application
6.4 North America Anti-infective Ophthalmic Breakdown Data by Countries
6.4.1 North America Anti-infective Ophthalmic Sales by Countries
6.4.2 North America Anti-infective Ophthalmic Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Anti-infective Ophthalmic Breakdown Data by Company
7.2 Europe Anti-infective Ophthalmic Breakdown Data by Type
7.3 Europe Anti-infective Ophthalmic Breakdown Data by Application
7.4 Europe Anti-infective Ophthalmic Breakdown Data by Countries
7.4.1 Europe Anti-infective Ophthalmic Sales by Countries
7.4.2 Europe Anti-infective Ophthalmic Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Anti-infective Ophthalmic Breakdown Data by Company
8.2 Asia Pacific Anti-infective Ophthalmic Breakdown Data by Type
8.3 Asia Pacific Anti-infective Ophthalmic Breakdown Data by Application
8.4 Asia Pacific Anti-infective Ophthalmic Breakdown Data by Regions
8.4.1 Asia Pacific Anti-infective Ophthalmic Sales by Regions
8.4.2 Asia Pacific Anti-infective Ophthalmic Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Anti-infective Ophthalmic Breakdown Data by Company
9.2 Latin America Anti-infective Ophthalmic Breakdown Data by Type
9.3 Latin America Anti-infective Ophthalmic Breakdown Data by Application
9.4 Latin America Anti-infective Ophthalmic Breakdown Data by Countries
9.4.1 Latin America Anti-infective Ophthalmic Sales by Countries
9.4.2 Latin America Anti-infective Ophthalmic Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Anti-infective Ophthalmic Breakdown Data by Type
10.2 Middle East and Africa Anti-infective Ophthalmic Breakdown Data by Application
10.3 Middle East and Africa Anti-infective Ophthalmic Breakdown Data by Countries
10.3.1 Middle East and Africa Anti-infective Ophthalmic Sales by Countries
10.3.2 Middle East and Africa Anti-infective Ophthalmic Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Novartis Anti-infective Ophthalmic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Novartis Anti-infective Ophthalmic Products and Services
11.1.5 Novartis SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Allergan Anti-infective Ophthalmic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Allergan Anti-infective Ophthalmic Products and Services
11.2.5 Allergan SWOT Analysis
11.2.6 Allergan Recent Developments
11.3 Bausch Health
11.3.1 Bausch Health Corporation Information
11.3.2 Bausch Health Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Bausch Health Anti-infective Ophthalmic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Bausch Health Anti-infective Ophthalmic Products and Services
11.3.5 Bausch Health SWOT Analysis
11.3.6 Bausch Health Recent Developments
11.4 Santen Pharmaceutical
11.4.1 Santen Pharmaceutical Corporation Information
11.4.2 Santen Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Santen Pharmaceutical Anti-infective Ophthalmic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Santen Pharmaceutical Anti-infective Ophthalmic Products and Services
11.4.5 Santen Pharmaceutical SWOT Analysis
11.4.6 Santen Pharmaceutical Recent Developments
11.5 Lupin Pharmaceuticals
11.5.1 Lupin Pharmaceuticals Corporation Information
11.5.2 Lupin Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Lupin Pharmaceuticals Anti-infective Ophthalmic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Lupin Pharmaceuticals Anti-infective Ophthalmic Products and Services
11.5.5 Lupin Pharmaceuticals SWOT Analysis
11.5.6 Lupin Pharmaceuticals Recent Developments
11.6 Apotex
11.6.1 Apotex Corporation Information
11.6.2 Apotex Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Apotex Anti-infective Ophthalmic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Apotex Anti-infective Ophthalmic Products and Services
11.6.5 Apotex SWOT Analysis
11.6.6 Apotex Recent Developments
11.7 Akorn
11.7.1 Akorn Corporation Information
11.7.2 Akorn Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Akorn Anti-infective Ophthalmic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Akorn Anti-infective Ophthalmic Products and Services
11.7.5 Akorn SWOT Analysis
11.7.6 Akorn Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Anti-infective Ophthalmic Sales Channels
12.2.2 Anti-infective Ophthalmic Distributors
12.3 Anti-infective Ophthalmic Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Anti-infective Ophthalmic Sales Forecast (2021-2026)
13.1.1 Global Anti-infective Ophthalmic Sales Forecast by Regions (2021-2026)
13.1.2 Global Anti-infective Ophthalmic Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Anti-infective Ophthalmic Sales Forecast (2021-2026)
13.2.2 North America Anti-infective Ophthalmic Revenue Forecast (2021-2026)
13.2.3 North America Anti-infective Ophthalmic Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Anti-infective Ophthalmic Sales Forecast (2021-2026)
13.3.2 Europe Anti-infective Ophthalmic Revenue Forecast (2021-2026)
13.3.3 Europe Anti-infective Ophthalmic Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Anti-infective Ophthalmic Sales Forecast (2021-2026)
13.4.2 Asia Pacific Anti-infective Ophthalmic Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Anti-infective Ophthalmic Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Anti-infective Ophthalmic Sales Forecast (2021-2026)
13.5.2 Latin America Anti-infective Ophthalmic Revenue Forecast (2021-2026)
13.5.3 Latin America Anti-infective Ophthalmic Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Anti-infective Ophthalmic Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Anti-infective Ophthalmic Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Anti-infective Ophthalmic Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Anti-infective Ophthalmic Key Market Segments
Table 2. Ranking of Global Top Anti-infective Ophthalmic Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-infective Ophthalmic Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Antibacterial
Table 5. Major Manufacturers of Antiviral
Table 6. Major Manufacturers of Antifungal
Table 7. Major Manufacturers of Anti-parasitic
Table 8. Major Manufacturers of Others
Table 9. Global Anti-infective Ophthalmic Market Share by Application 2019-2025 (K Units)
Table 10. Global Anti-infective Ophthalmic Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 11. Global Anti-infective Ophthalmic Sales by Regions 2015-2020 (K Units)
Table 12. Global Anti-infective Ophthalmic Sales Market Share by Regions 2015-2020
Table 13. Global Anti-infective Ophthalmic Revenue by Regions 2015-2020 (Million US$)
Table 14. Global Anti-infective Ophthalmic Revenue Market Share by Regions 2015-2020
Table 15. Top Anti-infective Ophthalmic Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 16. Market Top Trends
Table 17. Anti-infective Ophthalmic Key Drivers: Impact Analysis (2021-2026)
Table 18. Anti-infective Ophthalmic Key Challenges
Table 19. Main Points Interviewed from Key Anti-infective Ophthalmic Players: Views for Future
Table 20. Global Anti-infective Ophthalmic Sales by Manufacturers (2015-2020) (K Units)
Table 21. Global Anti-infective Ophthalmic Sales Share by Manufacturers (2015-2020)
Table 22. Anti-infective Ophthalmic Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Anti-infective Ophthalmic Revenue Share by Manufacturers (2015-2020)
Table 24. Global Anti-infective Ophthalmic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-infective Ophthalmic as of 2019)
Table 26. Key Manufacturers Anti-infective Ophthalmic Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 27. Key Manufacturers Anti-infective Ophthalmic Plants/Factories Distribution
Table 28. Key Manufacturers Anti-infective Ophthalmic Area Served
Table 29. Date of Key Manufacturers Enter into Anti-infective Ophthalmic Market
Table 30. Key Manufacturers Anti-infective Ophthalmic Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Antibacterial Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 33. Global Antiviral Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 34. Global Antifungal Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 35. Global Anti-parasitic Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 36. Global Others Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 37. Global Anti-infective Ophthalmic Sales (K Units) by Type (2015-2020)
Table 38. Global Anti-infective Ophthalmic Sales Share by Type (2015-2020)
Table 39. Global Anti-infective Ophthalmic Revenue (US$ Million) Market Share by Type (2015-2020)
Table 40. Global Anti-infective Ophthalmic Price (K Units) by Type (2015-2020)
Table 41. Global Anti-infective Ophthalmic Sales (K Units) by Type (2021-2026)
Table 42. Global Anti-infective Ophthalmic Sales Share by Type (2021-2026)
Table 43. Global Anti-infective Ophthalmic Revenue (US$ Million) Market Share by Type (2021-2026)
Table 44. Global Anti-infective Ophthalmic Revenue Share by Type (2021-2026)
Table 45. Global Anti-infective Ophthalmic Price (K Units) by Type (2021-2026)
Table 46. Global Anti-infective Ophthalmic Sales (K Units) by Application (2015-2020)
Table 47. Global Anti-infective Ophthalmic Sales Share by Application (2015-2020)
Table 48. Global Anti-infective Ophthalmic Revenue (US$ Million) Market Share by Application (2015-2020)
Table 49. Global Anti-infective Ophthalmic Price by Application 2015-2020 (USD/Unit)
Table 50. Global Anti-infective Ophthalmic Sales by Application (2015-2020) (K Units)
Table 51. Global Anti-infective Ophthalmic Sales Share by Application (2015-2020)
Table 52. Global Anti-infective Ophthalmic Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Global Anti-infective Ophthalmic Revenue Share by Application (2021-2026)
Table 54. Global Anti-infective Ophthalmic Price (K Units) by Application (2021-2026)
Table 55. North America Anti-infective Ophthalmic Sales by Company (2015-2020) (K Units)
Table 56. North America Anti-infective Ophthalmic Sales Market Share by Company (2015-2020)
Table 57. North America Anti-infective Ophthalmic Sales by Type (2015-2020) (K Units)
Table 58. North America Anti-infective Ophthalmic Sales Market Share by Type (2015-2020)
Table 59. North America Anti-infective Ophthalmic Sales by Application (2015-2020) (K Units)
Table 60. North America Anti-infective Ophthalmic Sales Market Share by Application (2015-2020)
Table 61. North America Anti-infective Ophthalmic Sales by Countries (2015-2020) (K Units)
Table 62. North America Anti-infective Ophthalmic Sales Market Share by Countries (2015-2020)
Table 63. North America Anti-infective Ophthalmic Revenue by Countries (2015-2020) (Million US$)
Table 64. North America Anti-infective Ophthalmic Revenue Market Share by Countries (2015-2020)
Table 65. Europe Anti-infective Ophthalmic Sales by Company (2015-2020) (K Units)
Table 66. Europe Anti-infective Ophthalmic Sales Market Share by Company (2015-2020)
Table 67. Europe Anti-infective Ophthalmic Sales by Type (2015-2020) (K Units)
Table 68. Europe Anti-infective Ophthalmic Sales Market Share by Type (2015-2020)
Table 69. Europe Anti-infective Ophthalmic Sales by Application (2015-2020) (K Units)
Table 70. Europe Anti-infective Ophthalmic Sales Market Share by Application (2015-2020)
Table 71. Europe Anti-infective Ophthalmic Sales by Countries (2015-2020) (K Units)
Table 72. Europe Anti-infective Ophthalmic Sales Market Share by Countries (2015-2020)
Table 73. Europe Anti-infective Ophthalmic Revenue by Countries (2015-2020) (Million US$)
Table 74. Europe Anti-infective Ophthalmic Revenue Market Share by Countries (2015-2020)
Table 75. Asia Pacific Anti-infective Ophthalmic Sales by Regions (2015-2020) (K Units)
Table 76. Asia Pacific Anti-infective Ophthalmic Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Anti-infective Ophthalmic Sales by Type (2015-2020) (K Units)
Table 78. Asia Pacific Anti-infective Ophthalmic Sales Market Share by Type (2015-2020)
Table 79. Asia Pacific Anti-infective Ophthalmic Sales by Application (2015-2020) (K Units)
Table 80. Asia Pacific Anti-infective Ophthalmic Sales Market Share by Application (2015-2020)
Table 81. Asia Pacific Anti-infective Ophthalmic Sales by Countries (2015-2020) (K Units)
Table 82. Asia Pacific Anti-infective Ophthalmic Sales Market Share by Regions (2015-2020)
Table 83. Asia Pacific Anti-infective Ophthalmic Revenue by Regions (2015-2020) (Million US$)
Table 84. Asia Pacific Anti-infective Ophthalmic Revenue Market Share by Regions (2015-2020)
Table 85. Latin America Anti-infective Ophthalmic Sales by Company (2015-2020) (K Units)
Table 86. Latin America Anti-infective Ophthalmic Sales Market Share by Company (2015-2020)
Table 87. Latin America Anti-infective Ophthalmic Sales by Type (2015-2020) (K Units)
Table 88. Latin America Anti-infective Ophthalmic Sales Market Share by Type (2015-2020)
Table 89. Latin America Anti-infective Ophthalmic Sales by Application (2015-2020) (K Units)
Table 90. Latin America Anti-infective Ophthalmic Sales Market Share by Application (2015-2020)
Table 91. Latin America Anti-infective Ophthalmic Sales by Countries (2015-2020) (K Units)
Table 92. Latin America Anti-infective Ophthalmic Sales Market Share by Countries (2015-2020)
Table 93. Latin America Anti-infective Ophthalmic Revenue by Countries (2015-2020) (Million US$)
Table 94. Latin America Anti-infective Ophthalmic Revenue Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Anti-infective Ophthalmic Sales by Type (2015-2020) (K Units)
Table 96. Middle East and Africa Anti-infective Ophthalmic Sales Market Share by Type (2015-2020)
Table 97. Middle East and Africa Anti-infective Ophthalmic Sales by Application (2015-2020) (K Units)
Table 98. Middle East and Africa Anti-infective Ophthalmic Sales Market Share by Application (2015-2020)
Table 99. Middle East and Africa Anti-infective Ophthalmic Sales by Countries (2015-2020) (K Units)
Table 100. Middle East and Africa Anti-infective Ophthalmic Sales Market Share by Countries (2015-2020)
Table 101. Middle East and Africa Anti-infective Ophthalmic Revenue by Countries (2015-2020) (Million US$)
Table 102. Middle East and Africa Anti-infective Ophthalmic Revenue Market Share by Countries (2015-2020)
Table 103. Novartis Company Details
Table 104. Novartis Description and Business Overview
Table 105. Novartis Anti-infective Ophthalmic Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Novartis Anti-infective Ophthalmic Sales Growth Rate (2015-2020)
Table 107. Novartis Anti-infective Ophthalmic Sales Market Share in Global Market
Table 108. Novartis Recent Development
Table 109. Allergan Company Details
Table 110. Allergan Description and Business Overview
Table 111. Allergan Anti-infective Ophthalmic Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Allergan Anti-infective Ophthalmic Sales Growth Rate (2015-2020)
Table 113. Allergan Anti-infective Ophthalmic Sales Market Share in Global Market
Table 114. Allergan Recent Development
Table 115. Bausch Health Company Details
Table 116. Bausch Health Description and Business Overview
Table 117. Bausch Health Anti-infective Ophthalmic Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Bausch Health Anti-infective Ophthalmic Sales Growth Rate (2015-2020)
Table 119. Bausch Health Anti-infective Ophthalmic Sales Market Share in Global Market
Table 120. Bausch Health Recent Development
Table 121. Santen Pharmaceutical Company Details
Table 122. Santen Pharmaceutical Description and Business Overview
Table 123. Santen Pharmaceutical Anti-infective Ophthalmic Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Santen Pharmaceutical Anti-infective Ophthalmic Sales Growth Rate (2015-2020)
Table 125. Santen Pharmaceutical Anti-infective Ophthalmic Sales Market Share in Global Market
Table 126. Santen Pharmaceutical Recent Development
Table 127. Lupin Pharmaceuticals Company Details
Table 128. Lupin Pharmaceuticals Description and Business Overview
Table 129. Lupin Pharmaceuticals Anti-infective Ophthalmic Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. Lupin Pharmaceuticals Anti-infective Ophthalmic Sales Growth Rate (2015-2020)
Table 131. Lupin Pharmaceuticals Anti-infective Ophthalmic Sales Market Share in Global Market
Table 132. Lupin Pharmaceuticals Recent Development
Table 133. Apotex Company Details
Table 134. Apotex Description and Business Overview
Table 135. Apotex Anti-infective Ophthalmic Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Apotex Anti-infective Ophthalmic Sales Growth Rate (2015-2020)
Table 137. Apotex Anti-infective Ophthalmic Sales Market Share in Global Market
Table 138. Apotex Recent Development
Table 139. Akorn Company Details
Table 140. Akorn Description and Business Overview
Table 141. Akorn Anti-infective Ophthalmic Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Akorn Anti-infective Ophthalmic Sales Growth Rate (2015-2020)
Table 143. Akorn Anti-infective Ophthalmic Sales Market Share in Global Market
Table 144. Akorn Recent Development
Table 145. Anti-infective Ophthalmic Distributors List
Table 146. Anti-infective Ophthalmic Customers List
Table 147. Global Anti-infective Ophthalmic Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 148. Global Anti-infective Ophthalmic Sales Forecast by Type 2021-2026 (K Units)
Table 149. Global Anti-infective Ophthalmic Sales Forecast by Application 2021-2026 (K Units)
Table 150. Global Anti-infective Ophthalmic Sales Forecast by Regions 2021-2026 (K Units)
Table 151. Global Anti-infective Ophthalmic Revenue Forecast by Regions 2021-2026 (Million US$)
Table 152. North America Anti-infective Ophthalmic Sales Forecast by Countries 2021-2026 (K Units)
Table 153. North America Anti-infective Ophthalmic Revenue Forecast by Countries 2021-2026
Table 154. Europe Anti-infective Ophthalmic Sales Forecast by Countries 2021-2026 (K Units)
Table 155. Europe Anti-infective Ophthalmic Revenue Market Share Forecast by Countries 2021-2026
Table 156. Asia Pacific Anti-infective Ophthalmic Sales Forecast by Regions 2021-2026 (K Units)
Table 157. Asia Pacific Anti-infective Ophthalmic Revenue Forecast by Regions 2021-2026 (Million US$)
Table 158. Latin America Anti-infective Ophthalmic Sales Forecast by Countries 2021-2026 (K Units)
Table 159. Latin America Anti-infective Ophthalmic Revenue Forecast by Countries 2021-2026 (Million US$)
Table 160. Middle East and Africa Anti-infective Ophthalmic Sales Forecast by Regions 2021-2026 (K Units)
Table 161. Middle East and Africa Anti-infective Ophthalmic Revenue Forecast by Regions 2021-2026 (Million US$)
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-infective Ophthalmic Product Picture
Figure 2. Global Anti-infective Ophthalmic Sales Market Shar by Type 2015-2026
Figure 3. Antibacterial Figures
Figure 4. Antiviral Figures
Figure 5. Antifungal Figures
Figure 6. Anti-parasitic Figures
Figure 7. Others Figures
Figure 8. Global Anti-infective Ophthalmic Sales Market Share by Application in 2019 & 2026
Figure 9. Hospital Use Use Case
Figure 10. Clinic Use Use Case
Figure 11. Household Use Case
Figure 12. Other Use Case
Figure 13. Anti-infective Ophthalmic Report Years Considered
Figure 14. Global Anti-infective Ophthalmic Market Size 2015-2026 (Million US$)
Figure 15. Global Anti-infective Ophthalmic Sales 2015-2020 (K Units)
Figure 16. Global Anti-infective Ophthalmic Market Size Market Share by Regions 2015-2020
Figure 17. Global Anti-infective Ophthalmic Sales Market Share by Regions in 2019
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Anti-infective Ophthalmic Sales Share by Manufacturers in 2019
Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-infective Ophthalmic Sales in 2019
Figure 21. Anti-infective Ophthalmic Value Share by Manufacturers in 2019
Figure 22. Anti-infective Ophthalmic Revenue Share by Manufacturers In 2019
Figure 23. Anti-infective Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Anti-infective Ophthalmic Revenue Share by Type (2015-2020)
Figure 25. Global Anti-infective Ophthalmic Revenue Growth Rate by Type in 2015 & 2019
Figure 26. Global Anti-infective Ophthalmic Market Share by Price Range (2015-2020)
Figure 27. Global Anti-infective Ophthalmic Revenue Share by Application (2015-2020)
Figure 28. Global Anti-infective Ophthalmic Revenue Growth Rate by Application in 2015 & 2019
Figure 29. North America Anti-infective Ophthalmic Revenue Growth Rate 2015-2020 (Million US$)
Figure 30. U.S. Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 31. Canada Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 32. Europe Anti-infective Ophthalmic Revenue Growth Rate 2015-2020 (Million US$)
Figure 33. Germany Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 34. France Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 38. Asia Pacific Anti-infective Ophthalmic Revenue Growth Rate 2015-2020 (Million US$)
Figure 39. China Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 40. Japan Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 41. South Korea Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 42. India Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 43. Australia Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 44. Taiwan Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 45. Indonesia Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 46. Thailand Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 47. Malaysia Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 48. Philippines Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 49. Vietnam Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 50. Latin America Anti-infective Ophthalmic Revenue Growth Rate 2015-2020 (Million US$)
Figure 51. Mexico Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 52. Brazil Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 53. Argentina Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 54. Middle East and Africa Anti-infective Ophthalmic Revenue Growth Rate 2015-2020 (Million US$)
Figure 55. Turkey Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 56. Saudi Arabia Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 57. U.A.E Anti-infective Ophthalmic Sales Growth Rate (2015-2020) (K Units)
Figure 58. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Santen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Anti-infective Ophthalmic Value Chain
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. North America Anti-infective Ophthalmic Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 69. North America Anti-infective Ophthalmic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Europe Anti-infective Ophthalmic Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 71. Europe Anti-infective Ophthalmic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Asia Pacific Anti-infective Ophthalmic Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 73. Asia Pacific Anti-infective Ophthalmic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Latin America Anti-infective Ophthalmic Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 75. Latin America Anti-infective Ophthalmic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Middle East and Africa Anti-infective Ophthalmic Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 77. Middle East and Africa Anti-infective Ophthalmic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed


【掲載企業】

Novartis、Allergan、Bausch Health、Santen Pharmaceutical、Lupin Pharmaceuticals、Apotex、Akorn

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗感染性眼科の世界市場2020-2026:抗菌剤、抗ウイルス剤、抗真菌剤、抗寄生虫剤、その他(Global Anti-infective Ophthalmic Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。